Michael Joseph Golembiewski Seelos Therapeutics, Inc. (SEEL) insider trading activity
Michael Joseph Golembiewski is Chief Financial Officer of SEELOS THERAPEUTICS, INC.. Currently has a direct ownership of 86,869 shares of SEEL, which is worth approximately $17,373. The most recent transaction as insider was on Feb 29, 2024, when has been sold 417 shares (Common Stock) at a price of $1.1 per share, resulting in proceeds of $458. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
86.9K
0%
3M change
16.06%
12M change
Total Value Held
$17,373
Michael Joseph Golembiewski Transaction History
MJG
Michael Joseph Golembiewski
Chief Financial Officer
New York, NY